High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells
AUTOR(ES)
Sugie, Katsuji
FONTE
The National Academy of Sciences of the USA
RESUMO
High-affinity binding was demonstrated between suppressor-T-cell-derived bioactive glycosylation-inhibiting factor (GIF) and helper T hybridomas and natural killer cell line cells. Inactive GIF present in cytosol of suppressor T cells and Escherichia coli-derived recombinant human GIF (rhGIF) failed to bind to these cells. However, affinity of rhGIF for the target cells was generated by replacement of Cys-57 in the sequence with Ala or of Asn-106 with Ser or binding of 5-thio-2-nitrobenzoic acid to Cys-60 in the molecule. Such mutations and the chemical modification of rhGIF synergistically increased the affinity of GIF molecules for the target cells. The results indicated that receptors on the target cells recognize conformational structures of bioactive GIF. Equilibrium dissociation constant (Kd) of the specific binding between bioactive rGIF derivatives and high-affinity receptors was 10–100 pM. Receptors for bioactive GIF derivatives were detected on Th1 and Th2 T helper clones and natural killer NK1.1+ cells in normal spleen but not on naive T or B cells. Neither the inactive rGIF nor bioactive rGIF derivatives bound to macrophage and monocyte lines or induced macrophages for tumor necrosis factor α production.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=24669Documentos Relacionados
- In vitro modulation of antigen-primed T cells by a glycosylation-inhibiting factor that regulates the formation of antigen-specific suppressive factors.
- Biochemical characterization of murine glycosylation-inhibiting factor.
- Association of the "major histocompatibility complex subregion" I-J determinant with bioactive glycosylation-inhibiting factor.
- Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor.
- Requirement of posttranslational modifications for the generation of biologic activity of glycosylation-inhibiting factor.
